Trial 106/Gleevec trial for Newly diagnosed at MDACC

[Guest guest]

Hi Giora and Cheryl-Anne,

Interesting about the 106. Perhaps Novartis is interested in following

up as many IM patients as possible. I am in the trial for newly

diagnosed at MDACC which started in April 2001, and I recently was

told that the trial was extended for 7.5-10 years. In that case it may

be worthwhile because of insurance issues to stay in the protocol as

long as my numbers are good.

Regards,

> >

> > hallo cheryl ann

> > as i have told lynne we have heard from one of the drs on the board

> of thr trial 106 that novartis has decided to keep following the

> patients on the gleevec arm. the interferon arm of this trial was

> closed after 1 year since almost all patients on this arm switched to

> gleevec.

> > as far as i understood the decision to continue the trial is not

> limited in time. when we joined the iris trial it was planned to

> continue for 5 years. i am now midway through the 6 th year.

> > shalom

> > giora

> > [ ] Trial 106 - Correction

> >

> >

> > Hello Lynn and Everyone,

> >

> > In reviewing the information a bit closer it seems that in fact

> trial

> > 106 may just well be closed. The information I have seen is that

> as of

> > their last update on their conditional approval status, which was

> dated

> > April 2003, they would have had to provide annual updates on

> trial 106

> > for three years. In January 2004, they would have provided

> reports for

> > 2003, In January 2005, they would have reported 2004, and in

> January

> > 2006, they would have reported for 2005 - three years.

> >

> > If anyone else is getting kicked off the trial or needs

> assistance,

> > please let me know, maybe I can help put you in touch with the

> right

> > person at Novartis.

> >

> > Cheers, Peace, Love and light,

> > Cheryl-Anne

> >

> >

> >

> >

> >

> >